Abstract
Curcumin is a naturally occurring constituent of turmeric that is a good substitute for synthetic medicines for the treatment of different diseases, due to its comparatively safer profile. However, there are certain shortcomings that limit its use as an ideal therapeutic agent. In order to overcome these drawbacks, we prepared novel curcumin-loaded mixed polymeric micelles using different biocompatible polymers by the thin-film hydration method. We investigated the critical micelle concentration and temperature, drug loading and encapsulation efficiency, and minimum inhibitory concentration by spectrophotometry. Surface morphology, stability, particle size, drug-polymer interaction, and physical state of the prepared formulations were investigated using scanning electron microscopy, zeta potential, particle size analyzer, Fourier-transform infrared spectroscopy, and X-ray diffraction, respectively. The drug loading and entrapment efficiency were significantly increased (P < 0.01) when curcumin was encapsulated with pluronic-based mixed polymeric micelles as compared to that of pluronic-based micelles alone. In vitro studies exhibited that pluronic-based mixed polymeric micelles significantly increased anticancer (P < 0.01), antimicrobial (P < 0.001), antioxidant (P < 0.001), and α-amylase inhibitory (P < 0.001) activities when compared to pure curcumin and/or pluronic-based micelles alone. These findings suggest that the formation of mixed polymeric micelles increases the stability and solubility of curcumin.
Similar content being viewed by others
References
Akram M, Uddin S, Ahmed A, Usmanghani K, Hannan A, Mohiuddin E, et al. Curcuma longa and curcumin: a review article. Rom J Biol Plant Biol. 2010;55(2):65–70.
Oliveira AS, Sousa E, Helena Vasconcelos M, Pinto M. Curcumin: a natural lead for potential new drug candidates. Curr Med Chem. 2015;22(36):4196–232.
Chauhan M, Saha S, Roy A. Curcumin: a review. J Applied Pharm Res. 2014;2(1):18–28.
Hani U, Shivakumar H. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review. Current Drug Delivery. 2014;11(6):792–804.
Akbar MU, Rehman K, Zia KM, Qadir MI, Akash MSH, Ibrahim M. Critical review on curcumin as a therapeutic agent: from traditional herbal medicine to an ideal therapeutic agent. Crit Rev Eukaryot Gene Expr. 2018;28(1):17–24.
Balasubramanian K. Molecular orbital basis for yellow curry spice curcumin’s prevention of Alzheimer’s disease. J Agric Food Chem. 2006;54(10):3512–20.
Lal J, Gupta SK, Thavaselvam D, Agarwal DD. Synthesis and pharmacological activity evaluation of curcumin derivatives. Chin Chem Lett. 2016;27(7):1067–72.
Bendary E, Francis R, Ali H, Sarwat M, El Hady S. Antioxidant and structure–activity relationships (SARs) of some phenolic and anilines compounds. Ann Agric Sci. 2013;58(2):173–81.
Namratha K, Shenai P, Chatra L, Rao PK, Veena KM, Prabhu RV. Antioxidant and anticancer effects of curcumin-a review. Çağdaş Tıp Dergisi. 2013;3(2):136–43.
Negi P, Jayaprakasha G, Jagan Mohan Rao L, Sakariah K. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999;47(10):4297–300.
Sharma R, Gescher A, Steward W. Curcumin: the story so far. Eur J Cancer. 2005;41(13):1955–68.
Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC. Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res. 2011;4(8):1158–71.
Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6(1):10.
Cheng A-L, Hsu C-H, Lin J-K, Hsu M-M, Ho Y-F, Shen T-S, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895–900.
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(04):353–6.
Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016;24(8):694–702.
Zhao L, Du J, Duan Y, Zhang H, Yang C, Cao F, et al. Curcumin loaded mixed micelles composed of pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B: Biointerfaces. 2012;97:101–8.
Yen F-L, Wu T-H, Tzeng C-W, Lin L-T, Lin C-C. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities. J Agric Food Chem. 2010;58(12):7376–82.
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–18.
Tønnesen HH, Másson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm. 2002;244(1):127–35.
Kurien BT, Singh A, Matsumoto H, Scofield RH. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay and Drug Development Technologies. 2007;5(4):567–76.
Yang X, Chen J, Guo D. Study of biocompatibility of polybutylcyanoacrylate nanoparticles. Di Yi Jun Yi Da Xue Xue Bao. 2005;25(10):1261–3.
Wang J, Ma W, Tu P. The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: in vitro and in vivo. Colloids Surf B: Biointerfaces. 2015;133:108–19.
Shelma R, Sharma CP. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability. Carbohydr Polym. 2013;95(1):441–8.
Anitha A, Maya S, Deepa N, Chennazhi K, Nair S, Tamura H, et al. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr Polym. 2011;83(2):452–61.
Ramalingam P, Yoo SW, Ko YT. Nanodelivery systems based on mucoadhesive polymer coated solid lipid nanoparticles to improve the oral intake of food curcumin. Food Res Int. 2016;84:113–9.
Sun M, Zhao L, Guo C, Cao F, Chen H, Zhao L, et al. Evaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticles. J Nanopart Res. 2012;14(2):705.
Tung BT, Duyen DT, Thuy HT, Hang HT, Diéguez K, Santana MC, Garrigues T, Binh NT, Hai NT. Pharmacokinetics of different pharmaceutical nano curcumin products by oral administration. Int J Phar Sci Nanotech. 2017;(6):3915–19.
Tsai Y-M, Jan W-C, Chien C-F, Lee W-C, Lin L-C, Tsai T-H. Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem. 2011;127(3):918–25.
Tomren M, Masson M, Loftsson T, Tønnesen HH. Studies on curcumin and curcuminoids: XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm. 2007;338(1–2):27–34.
Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007;330(1–2):155–63.
Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B, et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci. 2010;99(4):1871–81.
Duan C, Gao J, Zhang D, Jia L, Liu Y, Zheng D, et al. Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin. Biomacromolecules. 2011;12(12):4335–43.
Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem. 2009;57(19):9141–6.
Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong S-M, Pramanik D, et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther. 2010;9(8):2255–64.
Chacko RT, Ventura J, Zhuang J, Thayumanavan S. Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv Drug Deliv Rev. 2012;64(9):836–51.
Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371(1–2):148–55.
Ahmed K, Li Y, McClements DJ, Xiao H. Nanoemulsion- and emulsion-based delivery systems for curcumin: encapsulation and release properties. Food Chem. 2012;132(2):799–807.
Shaikh J, Ankola D, Beniwal V, Singh D, Kumar MR. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009;37(3–4):223–30.
Rasheed A, Ashok Kumar CK, VVNSS S. Cyclodextrins as drug carrier molecule: a review. Sci Pharm. 2008;76(4):567–98.
Gilbert JC, Richardson JL, Davies MC, Palin KJ, Hadgraft J. The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J Control Release. 1987;5(2):113–8.
Lenaerts V, Triqueneaux C, Quartern M, Rieg-Falson F, Couvreur P. Temperature-dependent rheological behavior of pluronic F-127 aqueous solutions. Int J Pharm. 1987;39(1–2):121–7.
Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci. 1998;6(2):105–12.
Miller SC, Donovan MD. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm. 1982;12(2–3):147–52.
Desai SD, Blanchard J. In vitro evaluation of Pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharm Sci. 1998;87(2):226–30.
Akash MSH, Rehman K. Recent progress in biomedical applications of Pluronic (PF127): pharmaceutical perspectives. J Control Release. 2015;209:120–38. https://doi.org/10.1016/j.jconrel.2015.04.032.
Jeong B, Kim SW, Bae YH. Thermosensitive sol–gel reversible hydrogels. Adv Drug Deliv Rev. 2012;64:154–62.
Tang Y-F, Du Y-M, Hu X-W, Shi X-W, Kennedy JF. Rheological characterisation of a novel thermosensitive chitosan/poly (vinyl alcohol) blend hydrogel. Carbohydr Polym. 2007;67(4):491–9.
Kumar S, Haglund BO, Himmelstein KJ. In situ-forming gels for ophthalmic drug delivery. J Ocul Pharmacol Ther. 1994;10(1):47–56.
Akash MSH, Rehman K, Chen S. Pluronic F127-based thermosensitive gels for delivery of therapeutic proteins and peptides. Polym Rev. 2014;54(4):573–97.
Akash MSH, Rehman K, Chen S. Natural and synthetic polymers as drug carriers for delivery of therapeutic proteins. Polym Rev. 2015;55(3):371–406.
Akash MSH, Rehman K, Chen S. Polymeric-based particulate systems for delivery of therapeutic proteins. Pharm Dev Technol. 2016;21(3):367–78. https://doi.org/10.3109/10837450.2014.999785.
Akash MSH, Rehman K, Li N, Gao JQ, Sun H, Chen S. Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. Pharm Res. 2012;29(12):3475–85. https://doi.org/10.1007/s11095-012-0843-0.
Akash MSH, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013;114(3):525–31. https://doi.org/10.1002/jcb.24402.
Alexandridis P. Poly (ethylene oxide)/poly (propylene oxide) block copolymer surfactants. Curr Opin Colloid Interface Sci. 1997;2(5):478–89.
Kabanov AV, Batrakova EV, Alakhov VY. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82(2):189–212.
Chowdhary RK, Chansarkar N, Sharif I, Hioka N, Dolphin D. Formulation of benzoporphyrin derivatives in pluronics. Photochem Photobiol. 2003;77(3):299–303.
Joshi A, Ding S, Himmelstein KJ. Reversible gelation compositions and methods of use. Google Patents; 1993.
Kulthe SS, Choudhari YM, Inamdar NN, Mourya V. Polymeric micelles: authoritative aspects for drug delivery. Designed Monomers and Polymers. 2012;15(5):465–521.
Jones M-C, Leroux J-C. Polymeric micelles—a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999;48(2):101–11.
Kabanov AV, Alakhov VY. Pluronic® block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst. 2002;19(1):1–72.
Kazunori K, Masayuki Y, Teruo O, Yasuhisa S. Block copolymer micelles as vehicles for drug delivery. J Control Release. 1993;24(1–3):119–32.
Sezgin Z, Yüksel N, Baykara T. Ilaç tasiyici sistemler olarak polimerik misellerin hazirlanmasi ve karakterizasyonu. Ankara Ecz Fak Derg. 2003;32:125–42.
Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47(1):113–31.
Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73(2):137–72.
Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, et al. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release. 1998;55(2):219–29.
Yu B, Okano T, Kataoka K, Kwon G. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. J Control Release. 1998;53(1):131–6.
Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B: Biointerfaces. 1999;16(1):3–27.
Klaikherd A, Nagamani C, Thayumanavan S. Multi-stimuli sensitive amphiphilic block copolymer assemblies. J Am Chem Soc. 2009;131(13):4830–8.
Bouchemal K, Agnely F, Koffi A, Ponchel G. A concise analysis of the effect of temperature and propanediol-1, 2 on Pluronic F127 micellization using isothermal titration microcalorimetry. J Colloid Interface Sci. 2009;338(1):169–76.
Torchilin V. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci. 2004;61(19):2549–59.
Mourya V, Inamdar N, Nawale R, Kulthe S. Polymeric micelles: general considerations and their applications. Ind J Pharm Educ Res. 2011;45:128–38.
Akash MSH, Rehman K, Chen S. Spice plant Allium cepa: dietary supplement for treatment of type 2 diabetes mellitus. Nutrition. 2014;30(10):1128–37. https://doi.org/10.1016/j.nut.2014.02.011.
Akash MSH, Rehman K, Tariq M, Chen S. Development of therapeutic proteins: advances and challenges. Turk J Biol. 2015;39(3):343–58.
Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303(5665):1818–22.
Oerlemans C, Bult W, Bos M, Storm G, Nijsen JFW, Hennink WE. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res. 2010;27(12):2569–89.
Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther. 2006;112(3):630–48.
Xiong X-B, Mahmud A, Uludağ H, Lavasanifar A. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells. Pharm Res. 2008;25(11):2555–66.
Varshosaz J, Tabbakhian M, Salmani Z. Designing of a thermosensitive chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin. The Open Drug Delivery Journal. 2008;2(1):61–70.
Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm. 1996;132(1–2):195–206.
Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly (ethylene glycol)/poly (ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials. 2005;26(9):1053–61.
Dey S, Sreenivasan K. Conjugation of curcumin onto alginate enhances aqueous solubility and stability of curcumin. Carbohydr Polym. 2014;99:499–507.
Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Kim SW, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001;72(1):191–202.
Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. Polyethylene glycol–phosphatidylethanolamine conjugate (PEG–PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm. 2006;315(1):148–57.
Schmolka IR. Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res A. 1972;6(6):571–82.
Schmolka IR. A review of block polymer surfactants. J Am Oil Chem Soc. 1977;54(3):110–6.
Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376(1–2):176–85.
Gaisford S, Beezer AE, Mitchell JC. Diode-array UV spectrometric evidence for cooperative interactions in binary mixtures of pluronics F77, F87, and F127. Langmuir. 1997;13(10):2606–7.
Saxena V, Hussain MD. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomedicine. 2012;7:713.
Jones R. Susceptibility tests: microdilution and macrodilution broth procedures. Manual of Clin Microbiol. 1985:972–7.
Mukherjee P, Balasubramanian R, Saha K, Saha B, Pal M. Antibacterial efficiency of Nelumbo nucifera (Nymphaeaceae) rhizomes extract. Indian Drugs. 1995;32(6):274–6.
Kabak M, Elmali A, Elerman Y, Durlu T. Conformational study and structure of bis-N, N′-p-bromo-salicylideneamine-1, 2-diaminobenzene. J Mol Struct. 2000;553(1):187–92.
Bagchi A, Mukherjee P, Bhowmick S, Raha A. Synthesis, characterization and antibacterial activity of a novel curcumin metal complex. Int J Drug Dev Res. 2015;7(2):011–4.
Bozin B, Mimica-Dukic N, Simin N, Anackov G. Characterization of the volatile composition of essential oils of some Lamiaceae spices and the antimicrobial and antioxidant activities of the entire oils. J Agric Food Chem. 2006;54(5):1822–8.
Xiao Z, Storms R, Tsang A. A quantitative starch–iodine method for measuring alpha-amylase and glucoamylase activities. Anal Biochem. 2006;351(1):146–8.
Toton E, Ignatowicz E, Bernard M, Kujawski J, Rybczynska M. Evaluation of apoptotic activity of new condensed pyrazole derivatives. J Physiol Pharmacol. 2013;64:115–23.
Kabanov AV, Batrakova EV, Alakhov VY. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic® block copolymers. J Control Release. 2003;91(1):75–83.
Kabanov AV, Batrakova EV, Miller DW. Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier. Adv Drug Deliv Rev. 2003;55(1):151–64.
Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82(1):105–14.
Misra R, Acharya S, Dilnawaz F, Sahoo SK. Sustained antibacterial activity of doxycycline-loaded poly (D, L-lactide-co-glycolide) and poly (ε-caprolactone) nanoparticles. Nanomedicine. 2009;4(5):519–30.
Mahajan HS, Mahajan PR. Development of grafted xyloglucan micelles for pulmonary delivery of curcumin: in vitro and in vivo studies. Int J Biol Macromol. 2016;82:621–7.
Yadav A, Lomash V, Samim M, Flora SJ. Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity. Chem Biol Interact. 2012;199(1):49–61.
Popat A, Karmakar S, Jambhrunkar S, Xu C, Yu C. Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity. Colloids Surf B: Biointerfaces. 2014;117:520–7.
Wang Y, Lu Z, Wu H, Lv F. Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. Int J Food Microbiol. 2009;136(1):71–4.
Mun S-H, Joung D-K, Kim Y-S, Kang O-H, Kim S-B, Seo Y-S, et al. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine. 2013;20(8–9):714–8.
Basniwal RK, Buttar HS, Jain V, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem. 2011;59(5):2056–61.
Yadav VR, Suresh S, Devi K, Yadav S. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech. 2009;10(3):752–62.
Chaibundit C, Ricardo NM, Costa FM, Yeates SG, Booth C. Micellization and gelation of mixed copolymers P123 and F127 in aqueous solution. Langmuir. 2007;23(18):9229–36.
Gaucher G, Satturwar P, Jones M-C, Furtos A, Leroux J-C. Polymeric micelles for oral drug delivery. Eur J Pharm Biopharm. 2010;76(2):147–58.
Akhtar F, Rizvi MMA, Kar SK. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv. 2012;30(1):310–20.
Panyam J, Zhou W-Z, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002;16(10):1217–26.
Anitha A, Deepagan V, Rani VD, Menon D, Nair S, Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydr Polym. 2011;84(3):1158–64.
Pandey S, Sah SP, Sah ML, Mishra D. An antioxidant potential of hydromethanolic extract of urtica parviflora roxb. J Basic Clin Pharm. 2010;1(3):191–5.
Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23(1):87.
Rehman K, Akash MSH. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? J Biomed Sci. 2017;118(11):3577–85. https://doi.org/10.1002/jcb.26097.
Parveen A, Akash MSH, Rehman K, Kyunn WW. Dual role of p21 in the progression of cancer and its treatment. Crit Rev Eukaryot Gene Expr. 2016;26(1):49–62. https://doi.org/10.1615/CritRevEukaryotGeneExpr.v26.i1.60.
Parveen A, Akash MSH, Rehman K, Kyunn WW. Recent investigations for discovery of natural antioxidants: a comprehensive review. Crit Rev Eukaryot Gene Expr. 2016;26(2):143–60. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2016015974.
ToDA S, Miyase T, Arichi H, Tanizawa H, Takino Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem Pharm Bull. 1985;33(4):1725–8.
Tan C, Xie J, Zhang X, Cai J, Xia S. Polysaccharide-based nanoparticles by chitosan and gum arabic polyelectrolyte complexation as carriers for curcumin. Food Hydrocoll. 2016;57:236–45.
Akash MSH, Rehman K, Sun H, Chen S. Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. Eur J Pharmacol. 2013;701(1–3):87–95. https://doi.org/10.1016/j.ejphar.2013.01.008.
Akash MSH, Shen Q, Rehman K, Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci. 2012;101(5):1647–58. https://doi.org/10.1002/jps.23057.
Rehman K, Tariq M, Akash MSH, Gillani Z, Qazi MH. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells. Chem Biol Drug Des. 2014;83(3):317–23. https://doi.org/10.1111/cbdd.12245.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Akbar, M.U., Zia, K.M., Nazir, A. et al. Pluronic-Based Mixed Polymeric Micelles Enhance the Therapeutic Potential of Curcumin. AAPS PharmSciTech 19, 2719–2739 (2018). https://doi.org/10.1208/s12249-018-1098-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-018-1098-9